2 A) and showed an increasing trend with the higher stage of CRC from 13.61% in the HC group to 23.03% in primary CRC and 52.06% in metastatic CRC (Fig. 2 C, D, and G).
← all excerpts
Single-Exosome Profiling Identifies ITGB3+ and ITGAM+ Exosome Subpopulations as Promising Early Diagnostic Biomarkers and Therapeutic Targets for Colorectal Cancer.
1
—
—